Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: Jacob Snyder who wrote (720)	2/24/2000 5:33:00 PM
From: OldAIMGuy	Read Replies (1) \| Respond to of 798

Hi JS, Since August of '99, the average cost of all the shares I've accumulated in BSX is $24+. Unfortunately these new shares are tied up for now as unprofitable. The remaining shares from earlier purchases are profitable enough that the overall account is still profitable. I figure I can bide my time. As you pointed out, everybody hates this stock and this product line. That's a sure sign that its over-sold. Best regards, Tom

To: Jacob Snyder who wrote (720)	1/20/2001 11:19:06 PM
From: Toby Zidle	Read Replies (1) \| Respond to of 798

Jacob, It's been about eleven months since you last posted on this thread. In February 2000, you wrote: "I've been accumulating 2002 calls 25s, whenever the stock is below 19. Now have 300 contracts, average price 4.81. May start buying the 2003s when they are available. I see zero downside potential, with the stock at 19, and the potential for the stock to hit 50 before those calls expire." Hindsight says we could lose 35% from your $19, and we're in the red at this moment. Tell me if you reevaluated and got out, or if you're more enthused than ever with the same long-term target.